One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood.v126.23.495.495
Copy DOI Journal: Blood |  Publication Date: Dec 3, 2015 |
 Citations: 2 |
Affiliation: Ospedale Niguarda Ca' Granda, Pharmacyclics (United States), AbbVie (United States), Jiangsu Province Hospital, University of California, San Diego, Ghent University Hospital, St Vincent's Hospital, University of Melbourne, Hadassah Medical Center, Gdańsk Medical University, Baker Hughes (Canada), City Of Hope National Medical Center, Copernicus Memorial Hospital, Medical University of Lodz, Rabin Medical Center, Tel Aviv University, University of Oxford, King's College Hospital, Norton Healthcare, Leeds Teaching Hospitals NHS Trust, Istituti di Ricovero e Cura a Carattere Scientifico, Vita-Salute San Raffaele University, The University of Texas MD Anderson Cancer Center, Medical University of Silesia, Peter MacCallum Cancer Centre, University of Rochester, North Shore Hospital, Institute of Blood Pathology and Transfusion Medicine of the National Academy of Medical Sciences of Ukraine, University Hospital Galway, Stanford University, University Hospital Brno, Royal Bournemouth Hospital, University of Eastern Piedmont Amadeo Avogadro, Washington University in St. LouisResults from the International, Randomized Phase 3 Study of Ibrutinib Versus Chlorambucil in Patients 65 Years and Older with Treatment-Naïve CLL/SLL (RESONATE-2TM)
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
